Together, our data suggest that Slc16a13 deletion attenuates the ectopic deposition of lipids in the liver, leading to a decrease in hepatic DAG content, lower PKCε activation, and, in turn, reduces diet-induced hepatic insulin resistance. The gene discussed is SLC16A13; the disease is Insulin resistance.